News Updates

More Articles Back to Article

Biotech center expected to improve access to CGTs in UK

A new biotechnology center in Bristol, England, is expected to alleviate manufacturing delays and improve patient access to clinical trials of cell and gene therapies, according to the UK's National Health Service Blood and Transplant. The NHSBT plans to continue increasing manufacturing capacity and is pursuing collaborations with third parties, according to a spokesperson. Pharmaceutical Technology (3/10)

Read full article now.

Articles are only one benefit of being a DIA member. Learn more and join today so you don’t miss another article!